ABBVIE INC (1ABBV.MI) Fundamental Analysis & Valuation
BIT:1ABBV • US00287Y1091
Current stock price
180.75 EUR
+0.9 (+0.5%)
Last:
This 1ABBV.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1ABBV.MI Profitability Analysis
1.1 Basic Checks
- 1ABBV had positive earnings in the past year.
- In the past year 1ABBV had a positive cash flow from operations.
- Each year in the past 5 years 1ABBV has been profitable.
- 1ABBV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.12%, 1ABBV is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
- 1ABBV has a better Return On Invested Capital (14.42%) than 86.90% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 13.21%.
- The last Return On Invested Capital (14.42%) for 1ABBV is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- 1ABBV has a Profit Margin of 6.84%. This is in the better half of the industry: 1ABBV outperforms 69.05% of its industry peers.
- In the last couple of years the Profit Margin of 1ABBV has declined.
- With an excellent Operating Margin value of 34.23%, 1ABBV belongs to the best of the industry, outperforming 86.90% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1ABBV has grown nicely.
- The Gross Margin of 1ABBV (71.62%) is better than 60.71% of its industry peers.
- 1ABBV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. 1ABBV.MI Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ABBV is creating some value.
- The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, 1ABBV has about the same amount of shares outstanding.
- The debt/assets ratio for 1ABBV is higher compared to a year ago.
2.2 Solvency
- 1ABBV has an Altman-Z score of 2.33. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
- 1ABBV's Altman-Z score of 2.33 is in line compared to the rest of the industry. 1ABBV outperforms 53.57% of its industry peers.
- 1ABBV has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as 1ABBV would need 3.79 years to pay back of all of its debts.
- 1ABBV has a Debt to FCF ratio of 3.79. This is in the better half of the industry: 1ABBV outperforms 77.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.33 |
ROIC/WACC1.68
WACC8.59%
2.3 Liquidity
- A Current Ratio of 0.67 indicates that 1ABBV may have some problems paying its short term obligations.
- 1ABBV has a Current ratio of 0.67. This is amonst the worse of the industry: 1ABBV underperforms 83.33% of its industry peers.
- 1ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- 1ABBV has a Quick ratio of 0.56. This is amonst the worse of the industry: 1ABBV underperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. 1ABBV.MI Growth Analysis
3.1 Past
- 1ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
- 1ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
- Looking at the last year, 1ABBV shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
- The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
- 1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. 1ABBV.MI Valuation Analysis
4.1 Price/Earnings Ratio
- 1ABBV is valuated rather expensively with a Price/Earnings ratio of 21.29.
- Compared to the rest of the industry, the Price/Earnings ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 77.38% of the companies listed in the same industry.
- 1ABBV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 14.35, 1ABBV is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 89.29% of the companies listed in the same industry.
- 1ABBV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.95.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 14.35 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 76.19% of the companies listed in the same industry.
- 85.71% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.13 | ||
| EV/EBITDA | 15 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of 1ABBV may justify a higher PE ratio.
- A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%
5. 1ABBV.MI Dividend Analysis
5.1 Amount
- 1ABBV has a Yearly Dividend Yield of 3.30%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.70, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 95.24% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, 1ABBV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
5.2 History
- The dividend of 1ABBV is nicely growing with an annual growth rate of 6.76%!
Dividend Growth(5Y)6.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 278.48% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
- 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
1ABBV.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1ABBV (4/9/2026, 7:00:00 PM)
180.75
+0.9 (+0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners76.17%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap319.60B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target215.03 (18.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
Yearly Dividend5.73
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.18%
PT rev (3m)0.73%
EPS NQ rev (1m)-3.54%
EPS NQ rev (3m)-1.6%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)-1.74%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 14.35 | ||
| P/S | 6.16 | ||
| P/FCF | 21.13 | ||
| P/OCF | 19.78 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15 |
EPS(TTM)8.49
EY4.7%
EPS(NY)12.6
Fwd EY6.97%
FCF(TTM)8.55
FCFY4.73%
OCF(TTM)9.14
OCFY5.05%
SpS29.36
BVpS-1.57
TBVpS-43.95
PEG (NY)0.44
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.33 |
F-Score8
WACC8.59%
ROIC/WACC1.68
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / 1ABBV.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
What is the valuation status for 1ABBV stock?
ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Undervalued.
How profitable is ABBVIE INC (1ABBV.MI) stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 7 / 10.
What is the financial health of ABBVIE INC (1ABBV.MI) stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.
What is the expected EPS growth for ABBVIE INC (1ABBV.MI) stock?
The Earnings per Share (EPS) of ABBVIE INC (1ABBV.MI) is expected to grow by 48.4% in the next year.